DEAGE
Live / Applied — New application — not yet assigned to an examiner (as of 11 Feb 2026)
What this means for you
Not registered yet, but its 11 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99647697
- Mark type
- Stylized text
- Filed
- 11 Feb 2026
- Attorney of record
- Andrew D. Bochner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses, degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease; Pharmaceutical preparations for the treatment of Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease; Medicinal preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses; Medicinal preparations for degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease, Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease; Medicinal preparations for Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease
Owner
- MDTB Cells GmbH, Radebeul, DE
Prosecution history
- 11 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Feb 2026 — NEW APPLICATION ENTERED